Neurological
1958 CE — Case series published by Astrom, Mancall, and Richardson, United States
Progressive multifocal leukoencephalopathy was a condition unknown to medicine until the twentieth century, first identified as a distinct entity in the late 1950s through the examination of brain tissue from patients who had suffered unusual and rapidly fatal neurological decline. Its recognition depended on advances in neuropathology and virology that allowed researchers to identify both the characteristic destruction of white matter and, eventually, the viral agent responsible. The history of the disease is inseparable from the history of immunosuppression and the scientific understanding of opportunistic infection.
Historical Narrative
Before the twentieth century, no record existed of the disease that would eventually be called progressive multifocal leukoencephalopathy because the condition was almost certainly vanishingly rare in populations without severe immunological compromise. Ancient and medieval physicians had no framework for understanding viral opportunism or for detecting the microscopic changes in brain white matter that define the condition, and any patients who might have suffered similar fates were likely recorded under broad categories of fatal brain disease or dementia.
The formal identification of the disease emerged from neuropathological work in the late 1950s. In 1958, Astrom, Mancall, and Richardson published a landmark description of three patients who had died after progressive neurological deterioration, all of whom were found at autopsy to have suffered from underlying diseases that severely compromised their immune function, including chronic lymphocytic leukemia and Hodgkin's lymphoma. Microscopic examination of their brains revealed an unusual and distinctive pattern of white matter destruction spread across multiple foci, alongside abnormally enlarged glial cells and bizarre, enlarged nuclei. The authors coined the name progressive multifocal leukoencephalopathy to capture the hallmarks of what they observed: a steadily worsening, multiply located destruction of the brain's white matter.
For several years following this description, the cause of the disease remained unknown. Researchers suspected an infectious agent because of the characteristic cellular changes and the tendency for the disease to appear in immunologically weakened patients, but no organism had been identified. The tools of mid-twentieth-century virology were still maturing, and isolation of novel viruses from human brain tissue was technically demanding.
The breakthrough came in 1971, when Padgett, Walker, and their colleagues successfully isolated a previously unknown virus from the brain of a patient with progressive multifocal leukoencephalopathy. The virus was named JC virus after the initials of that patient, following a naming convention of the era. This discovery established for the first time that the disease was caused by a viral infection targeting the glial cells responsible for producing myelin in the central nervous system. Electron microscopic studies confirmed the presence of viral particles within the abnormal nuclei that had puzzled the earlier neuropathologists.
Subsequent serological investigations through the 1970s revealed that JC virus infection was in fact widespread in the general population and that most people acquired the virus without apparent illness during childhood or early adulthood. This finding reframed the disease entirely: progressive multifocal leukoencephalopathy was understood not as a primary infection but as the result of viral reactivation in individuals whose immune systems could no longer hold the latent virus in check.
The epidemiology of the disease shifted dramatically with the emergence of HIV/AIDS in the 1980s. Physicians began encountering the condition with far greater frequency than the preceding decades had prepared them to expect, and it became recognized as a significant opportunistic disease in that epidemic context. This surge in cases prompted intensified research into the pathophysiology of JC virus and its relationship to immune status. The history of progressive multifocal leukoencephalopathy thus became a story about the intersection of virology, immunology, and the unforeseen consequences of conditions and therapies that altered the body's defenses against latent infections.
Key Historical Figures
Historical narrative only — this page describes how Progressive multifocal leukoencephalopathy was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.